Literature DB >> 32865751

Channelrhodopsins for Cell-Type Specific Illumination of Cardiac Electrophysiology.

Marbely C Fernández1,2,3, Ramona A Kopton1,2,3, Ana Simon-Chica1,2, Josef Madl1,2, Ingo Hilgendorf2,4, Callum M Zgierski-Johnston1,2, Franziska Schneider-Warme5,6.   

Abstract

Optogenetic approaches have evolved as potent means to investigate cardiac electrophysiology, with research ranging from the study of arrhythmia mechanisms to effects of cardiac innervation and heterocellular structural and functional interactions, both in healthy and diseased myocardium. Most commonly, these studies use channelrhodopsin-2 (ChR2)-expressing murine models that enable light-activated depolarization of the target cell population. However, each newly generated mouse line requires thorough characterization, as cell-type specific ChR2 expression cannot be taken for granted, and the electrophysiological response of its activation in the target cell should be evaluated. In this chapter, we describe detailed protocols for assessing ChR2 specificity using immunohistochemistry, isolation of specific cell populations to analyze electrophysiological effects of ChR2 activation with the patch-clamp technique, and whole-heart experiments to assess in situ effects of optical stimulation.

Entities:  

Keywords:  Cardiac optogenetics; Cardiomyocytes; Cell-type specific gene targeting; Electrocardiogram; Electrophysiology; Fibroblasts; Macrophages; Optical pacing; Transgenic mice

Mesh:

Substances:

Year:  2021        PMID: 32865751     DOI: 10.1007/978-1-0716-0830-2_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Novel insights into the electrophysiology of murine cardiac macrophages: relevance of voltage-gated potassium channels.

Authors:  Ana Simon-Chica; Marbely C Fernández; Eike M Wülfers; Achim Lother; Ingo Hilgendorf; Gunnar Seemann; Ursula Ravens; Peter Kohl; Franziska Schneider-Warme
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.